Chris Hugh Sananayake

Title: Chris Hugh Sananayake: Innovator in Respiratory Treatments

Introduction

Chris Hugh Sananayake is a notable inventor based in Brookfield, CT (US). He has made significant contributions to the field of respiratory medicine, particularly in the treatment of chronic obstructive pulmonary disease (COPD) and asthma. His innovative work has led to the development of novel compounds that aim to improve patient outcomes.

Latest Patents

Chris holds a patent for "Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma." This invention relates to novel piperidino-dihydrothienopyrimidine sulfoxides of formula I, which have potential therapeutic applications in managing respiratory conditions. He has 1 patent to his name, showcasing his commitment to advancing medical science.

Career Highlights

Chris is currently employed at Boehringer Ingelheim International GmbH, a leading global pharmaceutical company. His role involves research and development focused on innovative treatments for respiratory diseases. His expertise and dedication have positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

Throughout his career, Chris has collaborated with esteemed colleagues, including Pascale A J Pouzet and Peter Nickolaus. These partnerships have fostered a collaborative environment that enhances the innovation process and leads to groundbreaking discoveries in respiratory treatments.

Conclusion

Chris Hugh Sananayake exemplifies the spirit of innovation in the pharmaceutical industry. His contributions to respiratory medicine through his patent and work at Boehringer Ingelheim International GmbH highlight the importance of research and collaboration in developing effective treatments for chronic diseases.